The evaluation of theraputic effects for advanced renal cell carcinoma patients using axitinib; dose intensity, gene polymorphism and micro vascular density
Not Applicable
Recruiting
- Conditions
- Advanced Renal Cell Carcinoma
- Registration Number
- JPRN-UMIN000009833
- Lead Sponsor
- The department of urology, Graduate School of Medicine, Nagoya University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
unfit eligible criteria 1)ptotein uria 2+< 2)Pts had another cancers 3)Pts had myocardial infarction, pulumonary embolisim, brain infarction, heart failure, TIA, CABG within 6 months 4) pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method dose intensity, gene polymorphism and micro vascular density with axitinib
- Secondary Outcome Measures
Name Time Method clinical response using RECIST ver4.0, adverse event using CTCAE ver4.0, mapping in pathology